2nd Quarter - Report

THE OB-C GROUP, LLC for EMERGENT BIOSOLUTIONS INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

HR 361: Medical Preparedness Allowable Use Act; stockpiling of medical countermeasures for a chemical or biological attack

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 361 (114th)

Defense DEF

H.R 1735: National Defense Authorization Act for Fiscal Year 2016; provisions related to chemical decontamination. S.1118: National Defense Authorization Act for Fiscal Year 2016; provisions related to chemical decontamination.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1735 (114th), S. 1118 (114th)

Budget/Appropriations BUD

No bill number: Department of Labor, Health and Human Services , Education and Related Agencies; provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 2685: Department of Defense Appropriations 2016; provisions related to chemical decontamination and Ebola response preparedness. S. 1558: Department of Defense Appropriations 2016; provisions related to chemical decontamination and Ebola response preparedness.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1558 (114th), H.R. 2685 (114th)

Homeland Security HOM

H.R. 1300: First Responder Anthrax Preparedness Act; directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1300 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.